Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-06-16 4:54 pm Purchase | 13G | EVOLUS INC EOLS | Stonepine Capital Management LLC | 4,187,447 7.4% | 4,187,447 (New Position) | View |
2023-06-16 4:48 pm Purchase | 13G | AYTU BIOPHARMA INC PAR $0. AYTU | Stonepine Capital Management LLC | 563,842 9.99% | 563,842 (New Position) | View |
2023-06-09 4:29 pm Purchase | 13G | SCYNEXIS INC SCYX | Stonepine Capital Management LLC | 2,777,877 7.6% | 2,392,227 (+620.31%) | View |
2023-04-28 6:31 pm Purchase | 13G | ATYR PHARMA INC LIFE | Stonepine Capital Management LLC | 4,743,162 4.4% | 173,729 (+3.80%) | View |
2023-04-14 08:25 am Purchase | 13G | CTI BIOPHARMA CORP CTIC | Stonepine Capital Management LLC | 7,018,046 5.3% | 1,353,946 (+23.90%) | View |
2023-02-17 5:04 pm Purchase | 13G | ATYR PHARMA INC LIFE | Stonepine Capital Management LLC | 4,569,433 8.9% | 4,569,433 (New Position) | View |
2023-02-13 10:58 am Sale | 13G | EXAGEN INC XGN | Stonepine Capital Management LLC | 854,042 5.2% | -4,525 (-0.53%) | View |
2023-02-13 10:57 am Purchase | 13G | XERIS BIOPHARMA HLDGS INC XERS | Stonepine Capital Management LLC | 11,195,189 8.2% | 4,704,090 (+72.47%) | View |
2023-02-13 10:57 am Purchase | 13G | UROGEN PHARMA LTD URGN | Stonepine Capital Management LLC | 1,304,947 5.7% | 108,039 (+9.03%) | View |
2023-02-13 10:56 am Purchase | 13G | CONFORMIS INC CFMS | Stonepine Capital Management LLC | 748,194 9.9% | 748,194 (New Position) | View |
2023-02-13 10:55 am Sale | 13G | ADMA BIOLOGICS INC ADMA | Stonepine Capital Management LLC | 6,940,000 3.1% | -2,971,577 (-29.98%) | View |
2023-02-13 10:35 am Purchase | 13G | APOLLO ENDOSURGERY INC APEN | Stonepine Capital Management LLC | 4,351,088 9% | 1,695,959 (+63.87%) | View |
2023-02-13 10:29 am Purchase | 13G | REZOLUTE INC RZLT | Stonepine Capital Management LLC | 3,021,504 8.2% | 2,213,099 (+273.76%) | View |
2023-02-13 10:28 am Sale | 13G | OVID THERAPEUTICS INC OVID | Stonepine Capital Management LLC | 0 0% | -4,006,185 (Position Closed) | View |
2023-02-13 10:27 am Sale | 13G | CTI BIOPHARMA CORP CTIC | Stonepine Capital Management LLC | 5,664,100 4.5% | -4,090,835 (-41.94%) | View |
2023-02-13 10:24 am Purchase | 13G | AMRYT PHARMA PLC SPONSORED ADR AMYT | Stonepine Capital Management LLC | 31,666,195 9.9% | 1,317,320 (+4.34%) | View |
2023-01-18 6:03 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | Stonepine Capital Management LLC | 2,152,968 5.3% | 2,152,968 (New Position) | View |
2022-12-02 11:15 am Purchase | 13G | UROGEN PHARMA LTD URGN | Stonepine Capital Management LLC | 1,196,908 5.2% | 1,196,908 (New Position) | View |
2022-02-14 08:21 am Sale | 13G | ADMA BIOLOGICS INC ADMA | Stonepine Capital Management LLC | 9,911,577 5.1% | -61,300 (-0.61%) | View |
2022-02-11 7:47 pm Sale | 13G | ADAMAS PHARMACEUTICALS INC ADMS | Stonepine Capital Management LLC | 0 0% | -3,408,849 (Position Closed) | View |